Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Residual Disease”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652685
What this trial is testing

Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Ruijin Hospital 218
Testing effectiveness (Phase 2)UnknownNCT01883219
What this trial is testing

TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaStem Cell TransplantationMinimal Residual Disease
Nanfang Hospital, Southern Medical University 80
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Not applicableNot Yet RecruitingNCT07565857
What this trial is testing

Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer

Who this might be right for
Gastric-Esophageal Cancer
Natera, Inc. 1,000
Not applicableLooking for participantsNCT06043921
What this trial is testing

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

Who this might be right for
Pancreatic Cancer
Invitae Corporation 150
Not applicableLooking for participantsNCT07795528
What this trial is testing

Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma

Who this might be right for
Colon AdenocarcinomaStage I Colon CancerStage II Colon Cancer+1 more
Ruijin Hospital 392
Testing effectiveness (Phase 2)Looking for participantsNCT06005818
What this trial is testing

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
University of Alabama at Birmingham 100
Testing effectiveness (Phase 2)Looking for participantsNCT05414032
What this trial is testing

Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC

Who this might be right for
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
University Health Network, Toronto 102
Not applicableUnknownNCT02676570
What this trial is testing

Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method

Who this might be right for
Mycoses
Seoul St. Mary's Hospital 50
Very early researchLooking for participantsNCT07034742
What this trial is testing

Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 136
Large-scale testing (Phase 3)Looking for participantsNCT07750158
What this trial is testing

Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

Who this might be right for
Colorectal Cancer
Exelixis 600
Testing effectiveness (Phase 2)Looking for participantsNCT07407920
What this trial is testing

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage HER2-Positive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 120
Not applicableUnknownNCT04362462
What this trial is testing

Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Texas Tech University Health Sciences Center, El Paso 120
Not applicableUnknownNCT05802420
What this trial is testing

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdvanced CancerMetastatic Cancer
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00466726
What this trial is testing

Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 57
Testing effectiveness (Phase 2)Looking for participantsNCT06517212
What this trial is testing

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsBreast Cancers
Baylor Research Institute 48
Not applicableNot Yet RecruitingNCT07339384
What this trial is testing

Signatera Assessment in Early-Stage Endometrial Cancer

Who this might be right for
Endometrial Cancer
Natera, Inc. 1,010
Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Not applicableLooking for participantsNCT05457049
What this trial is testing

Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD

Who this might be right for
Non Small Cell Lung Cancer
Guangdong Association of Clinical Trials 180
Large-scale testing (Phase 3)Ended earlyNCT01827930
What this trial is testing

Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Institut Bergonié 68
Next Page